COL18A1 and neoplasm: Furthermore, treatment with rh-endostatin significantly increased the homing of CIK cells and tumor-infiltration lymphocytes and decreased the accumulation of MDSCs in the tumor tissue in vivo, providing new insight for combining anti-angiogenesis therapy with immunotherapy in the treatment of NSCLC [67].